4.6 Article

Combination treatment with platycodin D and osthole inhibits cell proliferation and invasion in mammary carcinoma cell lines

Journal

ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
Volume 36, Issue 1, Pages 115-124

Publisher

ELSEVIER
DOI: 10.1016/j.etap.2013.03.012

Keywords

Platycodin D; Osthole; Combination treatment; Murine 4T1 cells; Human MDA-MB-231 cells; Anti-invasion

Funding

  1. National Natural Science Foundation of China [81173269, 81102597, 81102598]
  2. Foundation of Shanghai Municipal Health Bureau [2010Y119]

Ask authors/readers for more resources

In this study, two invasive mammary carcinoma cells (MDA-MB-231 and 4T1) were utilized to evaluate the inhibitory activities of platycodin D, osthole, and the two in combination. The anti-proliferative effect was tested using the MTT and BrdU assay, and the combination of 15 mu M osthole and 75 mu M platycodin D was used for subsequent analyses. The anti-invasive effect was evaluated by the transwell assay. The results showed that the combination treatment reduced both cell proliferation and invasion. Western blot and real-time PCR revealed that the platycodin D-osthole combination significantly decreased T beta RII, Smad2, Smad3 and Smad4 gene or protein expressions, as well as effectively blocked TGF-beta-induced phosphorylation of Smad2 and Smad3. Thus, this study demonstrates that the anti-cancer effects of the platycodin D-osthole combination in breast cancer cells involve proliferation inhibition and invasion blockade, both of which maybe mediated by perturbations in the TGF-beta/Smads pathway. (C) 2013 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available